Group B Streptococcal Bacteriuria in Pregnancy: An Evidence-Based, Patient-Centered Approach to Care

J Midwifery Womens Health. 2020 May;65(3):376-381. doi: 10.1111/jmwh.13085. Epub 2020 Feb 25.

Abstract

Screening and management of group B streptococcus (GBS) bacteriuria in pregnancy aims to reduce the incidence of pyelonephritis and GBS-related neonatal morbidity and mortality. Universal screening and management of GBS bacteriuria in pregnancy are standards of care in the United States; however, some women may decline guideline-based recommendations for screening, treatment, or intrapartum antibiotic prophylaxis. This article uses a case study approach to discuss evidence-based, patient-centered care for GBS bacteriuria in pregnancy as well as ethical incorporation of individual patient preferences and values.

Keywords: asymptomatic bacteriuria; early-onset neonatal sepsis; group B streptococcus.

MeSH terms

  • Adult
  • Anti-Bacterial Agents
  • Antibiotic Prophylaxis
  • Bacteriuria / diagnosis*
  • Bacteriuria / drug therapy
  • Female
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control
  • Mass Screening
  • Patient-Centered Care
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis*
  • Pregnancy Complications, Infectious / drug therapy
  • Risk Factors
  • Streptococcal Infections / diagnosis*
  • Streptococcal Infections / drug therapy
  • Streptococcus agalactiae / isolation & purification
  • United States

Substances

  • Anti-Bacterial Agents